Known Prognostic Models Fail to Predict Outcomes for Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Affiliations

¹ Department of Medicine, University of Colorado, Aurora, Colorado, USA.
² Department of Biostatistics and Informatics, Anschutz Medical Campus, CIDA, Aurora, Colorado, USA.
³ Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
⁴ Division of Hematology, University of Colorado, Aurora, Colorado, USA.

Jason S Gilbert et al. Am J Hematol. 2025.

. 2025 Aug 14.

doi: 10.1002/ajh.70034. Online ahead of print.

¹ Department of Medicine, University of Colorado, Aurora, Colorado, USA.
² Department of Biostatistics and Informatics, Anschutz Medical Campus, CIDA, Aurora, Colorado, USA.
³ Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
⁴ Division of Hematology, University of Colorado, Aurora, Colorado, USA.

No abstract available

Keywords: AML—molecular diagnosis & therapy; chemotherapy; prediction modeling in cancer.

Publication types